New study checks for Drug-Cocaine interactions in volunteers
NCT ID NCT06343532
First seen Apr 30, 2026 · Last updated Apr 30, 2026
Summary
This early-stage study looked at whether the experimental drug SXC-2023 interacts with cocaine in 19 adults who use cocaine but are not seeking treatment. Participants received either the drug or a placebo, then were given intravenous cocaine to monitor safety and effects like heart rate and blood pressure. The goal was to understand potential risks, not to treat addiction.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COCAINE USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Clinical Kansas, Inc.
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.